Free shipping on all orders over $ 500
Juglanin, a natural occurring flavonoid, is a JNK acticator, with inflammation and anti-tumor activities. Juglanin can induce apoptosis and autophagy on human breast cancer cells.
| Molecular Weight | 418.35 |
| CAS Number | 5041-67-8 |
| Solubility (25°C) | DMSO 90 mg/mL |
| Storage | 2-8°C, dry, sealed |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[2] Guang Wang, et al. The Inhibitory Effects of Juglanin on Adipogenesis in 3T3-L1 Adipocytes
[5] Xinxin Chen, et al. Juglanin inhibits IL-1β-induced inflammation in human chondrocytes
| Related JNK Products |
|---|
| CC-90001
CC-90001 is a JNK (c-Jun N-terminal kinase) inhibitor that can be used as a Phase II clinical candidate to study idiopathic pulmonary fibrosis. |
| SU3327
SU3327 is a potent, selective and substrate-competitive JNK inhibitor with an IC50 of 0.7 μM. |
| L-JNKI-1
L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK. |
| JNK-IN-7
JNK-IN-7 is a potent JNK inhibitor with IC50 of 1.5, 2 and 0.7 nM for JNK1, JNK2 and JNK3, respectively. |
| D-JNKI-1
D-JNKI-1 (AM-111) is a highly potent and cell-permeable peptide inhibitor of JNK. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.
